54. Adult still disease Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 31 / Drugs : 39 - (DrugBank : 15) / Drug target genes : 12 - Drug target pathways : 116
Adult still disease and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 54 | Adult still disease | - |
| 13 | Multiple sclerosis/Neuromyelitis optica | 1.000 |
| 2 | Amyotrophic lateral sclerosis | 1.000 |
| 46 | Malignant rheumatoid arthritis | 1.000 |
| 49 | Systemic lupus erythematosus | 1.000 |
| 51 | Scleroderma | 1.000 |
| 84 | Sarcoidosis | 1.000 |
| 86 | Pulmonary arterial hypertension | 1.000 |
| 331 | Idiopathic multicentric castleman disease | 1.000 |
| 53 | Sjogren syndrome | 1.000 |
| 271 | Ankylosing spondylitis | 1.000 |
| 50 | Dermatomyositis | 1.000 |
| 56 | Behcet disease | 1.000 |
| 107 | Juvenile idiopathic arthritis | 1.000 |
| 40 | Takayasu arteritis | 1.000 |
| 41 | Giant cell arteritis | 1.000 |
| 42 | Polyarteritis nodosa | 1.000 |
| 43 | Microscopic polyangiitis | 1.000 |
| 55 | Relapsing polychondritis | 1.000 |
| 11 | Myasthenia gravis | 1.000 |
| 44 | Wegener granulomatosis | 1.000 |
| 266 | Familial mediterranean fever | 1.000 |